BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 19479701)

  • 1. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.
    Pons-Estel GJ; Alarcón GS; McGwin G; Danila MI; Zhang J; Bastian HM; Reveille JD; Vilá LM;
    Arthritis Rheum; 2009 Jun; 61(6):830-9. PubMed ID: 19479701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.
    Pons-Estel GJ; Alarcón GS; González LA; Zhang J; Vilá LM; Reveille JD; McGwin G;
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):393-400. PubMed ID: 20391486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria.
    Bastian HM; Alarcón GS; Roseman JM; McGwin G; Vilá LM; Fessler BJ; Reveille JD;
    Rheumatology (Oxford); 2007 Apr; 46(4):683-9. PubMed ID: 17132694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort.
    Durán-Barragán S; McGwin G; Vilá LM; Reveille JD; Alarcón GS;
    Rheumatology (Oxford); 2008 Jul; 47(7):1093-6. PubMed ID: 18511474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage.
    Toloza SM; Roseman JM; Alarcón GS; McGwin G; Uribe AG; Fessler BJ; Bastian HM; Vilá LM; Reveille JD
    Arthritis Rheum; 2004 Oct; 50(10):3177-86. PubMed ID: 15476246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis.
    Bastian HM; Roseman JM; McGwin G; Alarcón GS; Friedman AW; Fessler BJ; Baethge BA; Reveille JD;
    Lupus; 2002; 11(3):152-60. PubMed ID: 12004788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort.
    González LA; Pons-Estel GJ; Zhang J; Vilá LM; Reveille JD; Alarcón GS;
    Lupus; 2009 Aug; 18(9):822-30. PubMed ID: 19578107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term renal outcomes in multi-ethnic Southeast Asians with lupus nephritis: a retrospective cohort study.
    Lim CC; Tan HZ; Hao Y; Chin YM; Woo KT; Chan CM; Choo JCJ
    Intern Med J; 2018 Sep; 48(9):1117-1123. PubMed ID: 29740923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of renal function in patients with lupus nephritis and reduced renal function: the beneficial effect of hydroxychloroquine.
    Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Lupus; 2020 Jan; 29(1):52-57. PubMed ID: 31793379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children.
    Lau KK; Jones DP; Hastings MC; Gaber LW; Ault BH
    Pediatr Nephrol; 2006 May; 21(5):655-62. PubMed ID: 16570203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated With Tubulointerstitial Inflammation and Renal Scarring.
    Londoño Jimenez A; Mowrey WB; Putterman C; Buyon J; Goilav B; Broder A
    Arthritis Rheumatol; 2018 Nov; 70(11):1801-1806. PubMed ID: 29851285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.
    Hiraki LT; Feldman CH; Liu J; Alarcón GS; Fischer MA; Winkelmayer WC; Costenbader KH
    Arthritis Rheum; 2012 Aug; 64(8):2669-76. PubMed ID: 22847366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in African Americans and Hispanics with lupus nephritis.
    Contreras G; Lenz O; Pardo V; Borja E; Cely C; Iqbal K; Nahar N; de La Cuesta C; Hurtado A; Fornoni A; Beltran-Garcia L; Asif A; Young L; Diego J; Zachariah M; Smith-Norwood B
    Kidney Int; 2006 May; 69(10):1846-51. PubMed ID: 16598205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort.
    Andrade RM; Alarcón GS; Fernández M; Apte M; Vilá LM; Reveille JD;
    Arthritis Rheum; 2007 Feb; 56(2):622-30. PubMed ID: 17265497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: [corrected] contributions of admixture and socioeconomic status to renal involvement.
    Alarcón GS; Bastian HM; Beasley TM; Roseman JM; Tan FK; Fessler BJ; Vilá LM; McGwin G;
    Lupus; 2006; 15(1):26-31. PubMed ID: 16482742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of end stage renal disease in African Americans with lupus nephritis.
    Franco C; Yoo W; Franco D; Xu Z
    Bull NYU Hosp Jt Dis; 2010; 68(4):251-6. PubMed ID: 21162701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
    Fanouriakis A; Kostopoulou M; Cheema K; Anders HJ; Aringer M; Bajema I; Boletis J; Frangou E; Houssiau FA; Hollis J; Karras A; Marchiori F; Marks SD; Moroni G; Mosca M; Parodis I; Praga M; Schneider M; Smolen JS; Tesar V; Trachana M; van Vollenhoven RF; Voskuyl AE; Teng YKO; van Leew B; Bertsias G; Jayne D; Boumpas DT
    Ann Rheum Dis; 2020 Jun; 79(6):713-723. PubMed ID: 32220834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.
    Alarcón GS; McGwin G; Bartolucci AA; Roseman J; Lisse J; Fessler BJ; Bastian HM; Friedman AW; Reveille JD;
    Arthritis Rheum; 2001 Dec; 44(12):2797-806. PubMed ID: 11762940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
    Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH
    Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL).
    Reátegui-Sokolova C; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Serrano-Morales RM; Sacnun MP; Catoggio LJ; Soriano ER; García MA; Saurit V; Alvarellos A; Caeiro F; Berbotto GA; Sato EI; Borba Neto EF; Bonfa E; de Oliveira E Silva Montandon AC; Da Silva NA; Cavalcanti F; Vásquez G; Guibert-Toledano M; Reyes-Llerena GA; Massardo L; Neira OJ; Cardiel MH; Barile-Fabris LA; Amigo MC; Silveira LH; Portela-Hernández M; Garcia de la Torre I; Segami MI; Chacón-Diaz R; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA;
    RMD Open; 2020 Dec; 6(3):. PubMed ID: 33310863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.